investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death
Dean W Felsher
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Dean W Felsher
Stanford University
Stanford, United States
Related projects
Michael Clarke
Self-renewal of Normal and Leukemic Stem Cells
Leukaemia
Effie W Petersdorf
Clinical Significance of MHC Haplotypes in HCT
Leukaemia
Ross L Levine
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
Leukaemia
John D Schuetz
Metabolic pathways in leukemia
Leukaemia
Daniel G Tenen
Mechanisms of regulation by RNA in acute myeloid leukemia
Leukaemia
Hematology and hematologic malignancies
Pathology
Kapil Bhalla
Novel Targeted Therapy for AML
Leukaemia
Tomasz Skorski
BCR/ABL-PI-3k-ROS pathway induce genomic instability ....
Leukaemia
Hematology and hematologic malignancies
Pathology
Arnav Mehta
MicroRNA-125b physiologically and pathologically regulates myelopoiesis through I
Leukaemia
Wenwei Hu
The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer
Leukaemia